Personalis Ownership

PSNL Stock  USD 5.51  0.52  10.42%   
Personalis owns a total of 84.69 Million outstanding shares. Over half of Personalis' outstanding shares are owned by third-party entities. These third-party entities are typically referred to as corporate investors that secure positions in a given instrument to benefit from reduced trade commissions. On June 4, 2020, Representative Brian Mast of US Congress acquired $15k to $50k worth of Personalis's common stock.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Personalis. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Personalis Stock please use our How to buy in Personalis Stock guide.

Personalis Stock Ownership Analysis

About 16.0% of the company outstanding shares are owned by corporate insiders. The book value of Personalis was at this time reported as 2.36. The company has Price/Earnings To Growth (PEG) ratio of 0.09. Personalis recorded a loss per share of 1.73. The entity had not issued any dividends in recent years. Personalis, Inc. operates as a cancer genomics company worldwide. Personalis, Inc. was incorporated in 2011 and is headquartered in Menlo Park, California. Personalis operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 325 people. To find out more about Personalis contact Christopher Hall at 650 752 1300 or learn more at https://www.personalis.com.

Personalis Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Personalis insiders, such as employees or executives, is commonly permitted as long as it does not rely on Personalis' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Personalis insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Personalis' latest congressional trading

Congressional trading in companies like Personalis, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Personalis by those in governmental positions are based on the same information available to the general public.
2020-06-04Representative Brian MastAcquired $15K to $50KVerify
2020-05-04Representative Brian MastAcquired Under $15KVerify

Personalis Outstanding Bonds

Personalis issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Personalis uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Personalis bonds can be classified according to their maturity, which is the date when Personalis has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Personalis is a strong investment it is important to analyze Personalis' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Personalis' future performance. For an informed investment choice regarding Personalis Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Personalis. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Personalis Stock please use our How to buy in Personalis Stock guide.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Personalis. If investors know Personalis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Personalis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Personalis is measured differently than its book value, which is the value of Personalis that is recorded on the company's balance sheet. Investors also form their own opinion of Personalis' value that differs from its market value or its book value, called intrinsic value, which is Personalis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Personalis' market value can be influenced by many factors that don't directly affect Personalis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Personalis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Personalis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Personalis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.